ID   VIGLN_RAT               Reviewed;        1268 AA.
AC   Q9Z1A6;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   24-JUL-2024, entry version 129.
DE   RecName: Full=Vigilin;
DE   AltName: Full=High density lipoprotein-binding protein;
DE            Short=HDL-binding protein;
GN   Name=Hdlbp; Synonyms=Hbp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Vinten J., Tranum-Jensen J., Voldstedlund M., Christiansen K., Carlsen J.,
RA   Clausen H.;
RT   "Rat homologue of HBP.";
RL   Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31; SER-35 AND SER-645, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Appears to play a role in cell sterol metabolism. It may
CC       function to protect cells from over-accumulation of cholesterol (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U90725; AAD09246.1; -; mRNA.
DR   AlphaFoldDB; Q9Z1A6; -.
DR   SMR; Q9Z1A6; -.
DR   IntAct; Q9Z1A6; 1.
DR   STRING; 10116.ENSRNOP00000074707; -.
DR   iPTMnet; Q9Z1A6; -.
DR   PhosphoSitePlus; Q9Z1A6; -.
DR   jPOST; Q9Z1A6; -.
DR   PaxDb; 10116-ENSRNOP00000048476; -.
DR   UCSC; RGD:620962; rat.
DR   AGR; RGD:620962; -.
DR   RGD; 620962; Hdlbp.
DR   eggNOG; KOG2208; Eukaryota.
DR   InParanoid; Q9Z1A6; -.
DR   PhylomeDB; Q9Z1A6; -.
DR   Reactome; R-RNO-8964011; HDL clearance.
DR   PRO; PR:Q9Z1A6; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006869; P:lipid transport; IEA:UniProtKB-KW.
DR   CDD; cd22405; KH-I_Vigilin_rpt1; 1.
DR   CDD; cd22413; KH-I_Vigilin_rpt10; 1.
DR   CDD; cd22414; KH-I_Vigilin_rpt11; 1.
DR   CDD; cd22415; KH-I_Vigilin_rpt12; 1.
DR   CDD; cd22416; KH-I_Vigilin_rpt13; 1.
DR   CDD; cd22417; KH-I_Vigilin_rpt14; 1.
DR   CDD; cd22418; KH-I_Vigilin_rpt15; 1.
DR   CDD; cd22406; KH-I_Vigilin_rpt2; 1.
DR   CDD; cd22407; KH-I_Vigilin_rpt3; 1.
DR   CDD; cd22408; KH-I_Vigilin_rpt4; 1.
DR   CDD; cd22409; KH-I_Vigilin_rpt5; 1.
DR   CDD; cd02394; KH-I_Vigilin_rpt6; 1.
DR   CDD; cd22410; KH-I_Vigilin_rpt7; 1.
DR   CDD; cd22411; KH-I_Vigilin_rpt8; 1.
DR   CDD; cd22412; KH-I_Vigilin_rpt9; 1.
DR   Gene3D; 3.30.1370.10; K Homology domain, type 1; 14.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   PANTHER; PTHR10627; SCP160; 1.
DR   PANTHER; PTHR10627:SF34; VIGILIN; 1.
DR   Pfam; PF00013; KH_1; 14.
DR   SMART; SM00322; KH; 14.
DR   SUPFAM; SSF54791; Eukaryotic type KH-domain (KH-domain type I); 12.
DR   PROSITE; PS50084; KH_TYPE_1; 14.
PE   1: Evidence at protein level;
KW   Acetylation; Cholesterol metabolism; Cytoplasm; HDL; Lipid metabolism;
KW   Lipid transport; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   RNA-binding; Steroid metabolism; Sterol metabolism; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q00341"
FT   CHAIN           2..1268
FT                   /note="Vigilin"
FT                   /id="PRO_0000050133"
FT   DOMAIN          150..212
FT                   /note="KH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          222..284
FT                   /note="KH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          295..357
FT                   /note="KH 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          364..424
FT                   /note="KH 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          435..497
FT                   /note="KH 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          507..570
FT                   /note="KH 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          581..643
FT                   /note="KH 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          653..716
FT                   /note="KH 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          727..790
FT                   /note="KH 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          800..863
FT                   /note="KH 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          873..967
FT                   /note="KH 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          972..1034
FT                   /note="KH 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          1052..1117
FT                   /note="KH 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          1127..1190
FT                   /note="KH 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REGION          910..946
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1214..1268
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        928..946
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1230..1252
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00341"
FT   MOD_RES         8
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00341"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00341"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         35
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         295
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         296
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         317
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00341"
FT   MOD_RES         437
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00341"
FT   MOD_RES         645
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         991
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDJ3"
FT   MOD_RES         1247
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00341"
SQ   SEQUENCE   1268 AA;  141584 MW;  7F1FE9C2ED3E560E CRC64;
     MSSVAVLTQE SFAEHRSGLV PQQIIVATLN SEEESDPPTY KDAFPPLPEK AACLESAQEP
     AGAWSNKIRP IKASVITQVF HVPLEERKYK DMNQFGEGEQ AKICLEIMQR TGAHLELSLA
     KDQGLSIMVS GKLDAVMKAR KDIVARLQTQ ASATVPIPKE HHRFVIGKNG EKLQDLELKT
     ATKIQIPRPD DPSNQIKITG TKEGIEKARH EVLLISAEQD KRAVKRLEVE KAFHPFIAGP
     YNRLVGEIMQ ETGTRINIPP PSVNRTEIVF TGEKEQLAQA VARIKKIYEE KKKKTTTIAV
     EVKKSQHKYV IGPKGNSLQE ILERTGVSVE IPPSDSISET VILRGEPEKL GQALTEVYAK
     ANSFTVSSVS APSWLHRFII GKKGQNLAKI THQMPKVHIE FTEGEDKITL EGPTEDVNVA
     QEQIEGMVKD LINRMDYVEI NIDHKFHRHL IGKSGANINR IKDQYKVSVR IPPDSEKSNL
     IRIEGDPQGV QQAKRELLEL ASRMENERTK DLIIEQRFHR TIIGQKGERI REIRDKFPEV
     IINFPDPAQK SEIVQLRGPK NEVEKCTKYM QKMVADLVEN SYSISVPIFK QFHKNIIGKG
     GANIKKIREE SNTKIDLPAE NSNSETIVIT GKRANCEAAR SRILSIQKDL ANIAEVEVSI
     PAKLHNSLIG TKGRLIRSIM EECGGVHIHF PVEGSGSDTV VIRGPSSDVE KAKKQLLHLA
     EEKQTKSFTV DIRAKPEYHK FLIGKGGGKI RKVRDSTGAR IIFPAAEDKD QDLITIIGKE
     DAVREAQKEL EALIQNLDNV VEDYMLVDPR HHRHFVIRRG QVLREIAEEY GGVMVSFPRS
     GTQSDKVTLK GAKDCVEAAK KRIQEIIEDL EAQVTLECAI PQKFHRSVMG PKGSRIQQIT
     RDYNVQIKFP DREENPVHSV EPSIQENGDE AGEGREAKET DPGSPRRCDI IVISGRKEKC
     EAAKEALEAL VPVTIEVEVP FDLHRYIIGQ KGSGIRKMMD EFEVNIHVPA PELQSHTIAI
     TGLAANLDRA KAGLLDRVKE LQAEQEDRAL RSFKLSVTVD PKYHPKIIGG KGAVITQIRL
     EHDVNIQFPD KDDGNQPQDQ ITITGYEKNT EAARDAILKI VGELEQMVSE DVPLDHRVHA
     RIIGARGKAI RKIMDEFKVD IRFPQSGAPD PNCVTVTGLP ENVEEAIDHI LNLEEEYLAD
     VVDSEALQVY MKPPAHEESK APSKGFVVRD APWTSNSSEK APDMSSSEEI PTFGAQVAPK
     TLPWGPKR
//
